CapsoVision (CV) Total Liabilities (2024 - 2025)
CapsoVision recorded quarterly Total Liabilities of $4.9 million in Q4 2025, down 6.04% quarter-over-quarter from $5.2 million in Q3 2025, and up 82.44% year-over-year from $2.7 million in Q4 2024.
CapsoVision's Total Liabilities history runs 2 years deep, the most recent figure standing at $4.9 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 82.44% year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (up 82.44% YoY), while the FY2025 annual figure was $4.9 million, up 82.44% from the prior year.
- Total Liabilities came in at $4.9 million for Q4 2025 at CapsoVision, down from $5.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $125.0 million in Q3 2024 to a low of $2.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 57.73 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 18.25 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 18.55 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.68 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.54 Bn |
| 10 | CapsoVision | 167.59 Mn | 157.48 Mn | 1.95 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.90 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 124.99 Mn |
| Jun 30, 2024 | 119.21 Mn |